US20220072534A1 - Connector for Creating Platelet Rich Plasma - Google Patents
Connector for Creating Platelet Rich Plasma Download PDFInfo
- Publication number
- US20220072534A1 US20220072534A1 US17/525,719 US202117525719A US2022072534A1 US 20220072534 A1 US20220072534 A1 US 20220072534A1 US 202117525719 A US202117525719 A US 202117525719A US 2022072534 A1 US2022072534 A1 US 2022072534A1
- Authority
- US
- United States
- Prior art keywords
- connector
- tube
- syringe
- distal end
- specimen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 210000004623 platelet-rich plasma Anatomy 0.000 title description 43
- 239000012530 fluid Substances 0.000 claims abstract description 179
- 238000000034 method Methods 0.000 claims abstract description 51
- 210000004369 blood Anatomy 0.000 claims description 38
- 239000008280 blood Substances 0.000 claims description 38
- 239000012780 transparent material Substances 0.000 claims description 3
- 210000002381 plasma Anatomy 0.000 description 76
- 210000001772 blood platelet Anatomy 0.000 description 38
- 238000012546 transfer Methods 0.000 description 32
- 210000003743 erythrocyte Anatomy 0.000 description 30
- 230000008569 process Effects 0.000 description 16
- 238000007789 sealing Methods 0.000 description 11
- 239000000470 constituent Substances 0.000 description 8
- 238000000605 extraction Methods 0.000 description 7
- 239000003146 anticoagulant agent Substances 0.000 description 6
- 229940127219 anticoagulant drug Drugs 0.000 description 6
- 238000005119 centrifugation Methods 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 239000013536 elastomeric material Substances 0.000 description 4
- 210000001754 blood buffy coat Anatomy 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 238000004820 blood count Methods 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 238000009533 lab test Methods 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 206010069803 Injury associated with device Diseases 0.000 description 1
- 240000007643 Phytolacca americana Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000007863 gel particle Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5021—Test tubes specially adapted for centrifugation purposes
- B01L3/50215—Test tubes specially adapted for centrifugation purposes using a float to separate phases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/02—Blood transfusion apparatus
- A61M1/029—Separating blood components present in distinct layers in a container, not otherwise provided for
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
- A61M1/3482—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate by filtrating the filtrate using another cross-flow filter, e.g. a membrane filter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3496—Plasmapheresis; Leucopheresis; Lymphopheresis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D21/00—Separation of suspended solid particles from liquids by sedimentation
- B01D21/26—Separation of sediment aided by centrifugal force or centripetal force
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5021—Test tubes specially adapted for centrifugation purposes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/56—Labware specially adapted for transferring fluids
- B01L3/563—Joints or fittings ; Separable fluid transfer means to transfer fluids between at least two containers, e.g. connectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3693—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits using separation based on different densities of components, e.g. centrifuging
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/02—Adapting objects or devices to another
- B01L2200/026—Fluid interfacing between devices or objects, e.g. connectors, inlet details
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/06—Auxiliary integrated devices, integrated components
- B01L2300/0609—Holders integrated in container to position an object
- B01L2300/0618—Holders integrated in container to position an object for removable separation walls
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0848—Specific forms of parts of containers
- B01L2300/0858—Side walls
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0475—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure
- B01L2400/0478—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure pistons
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/56—Labware specially adapted for transferring fluids
- B01L3/563—Joints or fittings ; Separable fluid transfer means to transfer fluids between at least two containers, e.g. connectors
- B01L3/5635—Joints or fittings ; Separable fluid transfer means to transfer fluids between at least two containers, e.g. connectors connecting two containers face to face, e.g. comprising a filter
Definitions
- the invention relates to a method of needless fluid transfer from specimen collection tubes into syringes.
- the invention and the method have applications in biological, pharmaceutical, and medical fields where extraction of fluids and separation of fluid fractions take place.
- a preparation of platelet rich plasma (PRP) and separation of platelet poor plasma (PPP) from whole blood are just some of many uses for the device that employ the method of transfer described herein.
- PRP Platelet Rich Plasma
- RBC red blood cells
- PPP Platelet Poor Plasma
- the central part in the process of PRP preparation is prompt separation of blood fractions. Undisturbed blood left alone will separate on its own, due to gravity forces into density layers, but usually a centrifuge is used to accelerate the process.
- first spin a first spin cycle
- red blood cells RBC
- buffy coat leukocytes and platelets
- the buffy coat and plasma collectively Platelet Enriched Plasma (PEP), which contains slightly concentrated platelets (up to two times normal blood count) are transferred to a second tube ( FIG. 1D ) for a second spin to further concentrate the platelets.
- PEP Platelet Enriched Plasma
- FIG. 1E the PEP will separate into Platelet Pallet (PP) and plasma with very few (substantially no) platelets called Platelet Poor Plasma (PPP). See, FIG. 1E .
- PPP PPP
- the remaining plasma is mixed with Platelet Pallet.
- the resulting mixture is called PRP with platelet concentration of 4-8 (or more) times normal blood count. See, FIG. 1F .
- a syringe is used to aspirate the plasma and buffy coat through a needle, in order to transfer both into a second tube for a second spin.
- a small diameter syringe and/or a long needle are required.
- the separating gel acts as a semi-permeable membrane. During centrifugation, RBC is forced to pass through the gel and collects beneath it, which leaves plasma and buffy coat physically separated above it. After centrifugation, the gel functions as a barrier, allowing the tube to be tilted or turned up-side down (to facilitate aspiration of the buffy coat and plasma), without causing the RBC to mix with the buffy coat and plasma.
- the mixture of buffy coat and plasma is called Platelets Enriched Plasma (PEP).
- PEP Platelets Enriched Plasma
- a syringe is used to aspirate the PEP through a needle, in order to transfer it into a second tube to undergo a second spin. See, FIGS. 2C and 2D .
- the present invention addresses the shortcomings of the existing methods for transferring fluid density layers from specimen tubes into syringes.
- PRP preparation it is a system which makes it possible to transfer a chosen layer of blood fraction after centrifugation, from a fluid collection tube to a syringe or a syringe-like receptacle, without the need for needles and without relying solely on negative pressure aspiration.
- the present invention also eliminates the need for separating gel, because it allows a precise transfer of plasma and buffy coat to a syringe or syringe-like device, with minimal RBC contamination. This is possible because the transfer of the lightest density fluid, which has a tendency to stay on top of heavier density fluids, always takes place first, and the quantity being transferred can be easily controlled.
- Eliminating the separating gel also eliminates the possibility of contaminating the plasma with gel particles; it also significantly reduces the cost to the operator as well as to the patient. Elimination of needles diminishes the risk of sample contamination and the risk of accidental needle poke that could lead to the transmission of infectious diseases (bacteria, viruses) to the operator.
- the present invention also eliminates the need for a second fluid collection tube and for the transfer syringe (used to transfer the product of the first spin (PEP) from the first tube into the second tube to perform the second spin).
- PEP first spin
- the core parts of the invention are a tube seal and a barrel, both of which allow transfer (or extraction) of the plasma (PPP/PEP) from the tube, without use of needles, directly into the barrel, eliminating error associated with precisely positioning the needle within a thin layer of buffy coat.
- the barrel having diameter allowing it to be advanced into the tube, is serving as a perfect receptacle for acquiring the specimen from the tube, and having no flanges is perfect for insertion into the centrifuge.
- the barrel featuring a female Luer tip (Luer taper), allows easy transfer of plasma directly into the injection syringe, without need for connectors.
- the present invention allows the continuation of the process to the second centrifugation to obtain optimal two-spin PRP.
- Example 1 A method for transferring one or more portions of fluid from a specimen tube, comprising:
- the connector comprises an elongated tube having a lumen or through-hole extending between proximal and distal ends thereof, a Luer-compatible female taper provided on the proximal end of the connector, a flange provided proximate the distal end of the connector;
- the tube seal mounted on the distal end of the connector, the tube seal comprising an elastomeric member having a longitudinal axis, a proximal end, a distal end, and a through-hole extending therebetween, the distal end having a frustoconical or chamfered face forming a funnel, the elastomeric member having an outer diameter sized to sealingly engage with an inner surface of the specimen tube;
- the funnel directing the first layer into the through-hole of the connector, wherein the distal end of the connector and the tube seal are advanced until the first layer at least partially fills the comprises, through-hole of the connector, thereby de-airing the connector;
- Example 2 The method of Example 1 wherein the distal end of connector is provided with a Luer-compatible male or female taper.
- Example 3 The method of Example 1, wherein:
- the fluid specimen is blood
- the step of centrifuging the specimen tube separates the blood into a layer of plasma, a layer of buffy coat, and a layer of RBC, wherein the plasma has a density D 1 , the buffy coat has a density D 2 and the RBC has a density D 3 such that D 3 >D 2 >D 1 ;
- Example 4 The method of Example 3, wherein
- Example 5 A connector, comprising:
- an elongate tubular member having a proximal end, a distal end, and a lumen or through-hole extending therebetween, the tubular member formed of at least partially of a transparent or semi-transparent material;
- a first Luer-compatible female taper provided on the proximal end of the connector
- a flange provided proximate the distal end of the connector.
- Example 6 The connector of Example 5, a second Luer-compatible male or female taper provided on the distal end of the connector.
- Example 7 The connector of Example 5 further comprising a tube seal mounted on the distal end of the connector, the tube seal including an elastomeric member having a longitudinal axis, a proximal end, a distal end, and a through-hole extending therebetween, the distal end having a frustoconical or chamfered face forming a funnel, the elastomeric member having an outer diameter sized to sealingly engage with an inner surface of a specimen tube.
- Example 8 A method for transferring one or more portions of fluid from a specimen tube into a syringe, comprising:
- tube seal includes an elastomeric member having a longitudinal axis, a proximal end, a distal end, and a through-hole extending therebetween, the distal end having a frustoconical or chamfered face forming a funnel, the elastomeric member having an outer diameter sized to sealingly engage with an inner surface of the specimen tube;
- the connector comprises an elongated tube having a lumen or through-hole extending between proximal and distal ends thereof, a Luer-compatible female taper provided on the proximal end of the connector, a flange provided proximate the distal end of the connector;
- the funnel directing the first layer of fluid into the through-hole of the connector, wherein the distal end of the connector and the tube seal are advanced until the first layer of fluid fills the through-hole of the connector, thereby de-airing the connector;
- Example 9 A method for making platelet enriched plasma, comprising:
- the connector comprises an elongated tube having a lumen or through-hole extending between proximal and distal ends thereof, a Luer-compatible female taper provided on the proximal end of the connector, a flange provided proximate the distal end of the connector;
- the tube seal mounted on the distal end of the connector, the tube seal comprising an elastomeric member having a longitudinal axis, a proximal end, a distal end, and a through-hole extending therebetween, the distal end having a frustoconical or chamfered face forming a funnel, the elastomeric member having an outer diameter sized to sealingly engage with an inner surface of the specimen tube;
- the funnel directing the plasma into the through-hole of the connector, wherein the distal end of the connector is advanced until the plasma at least partially fills the comprises, through-hole of the connector, thereby de-airing the connector;
- FIG. 1A shows a fluid collection tube with anticoagulant
- FIG. 1B shows the fluid collection tube of FIG. 1A with a sample of whole blood
- FIG. 1C shows the fluid collection tube of FIG. 1B after it has been centrifuged
- FIG. 1D shows a fluid collection tube of FIG. 1C containing plasma and buffy coat after the red blood cells have been removed;
- FIG. 1E shows the fluid collection tube of FIG. 1D after it has been centrifuged
- FIG. 1F shows the fluid collection tube of FIG. 1E after 3 ⁇ 4 of the plasma has been removed leaving 1 ⁇ 4 of the plasma and the platelet pallet (collectively PRP)
- FIG. 2A depicts a fluid collection tube containing separating gel and anti-coagulant
- FIG. 2B depicts the fluid collection tube of FIG. 2A with a sample of whole blood
- FIG. 2C depicts the fluid collection tube of FIG. 2B after it has been centrifuged
- FIG. 2D shows a syringe attached to the fluid collection tube of FIG. 2C
- FIGS. 3A-3C are drawings illustrating examples of the tube seal in a fluid collection tube
- FIGS. 4A-4D show a needleless transfer method for transferring fluid from a fluid collection tube into a syringe using the tube seal
- FIGS. 5A-5D show a method for inserting a tube seal into a fluid collection tube using a dispenser
- FIG. 6 shows a fully assembled view and an exploded view of device 100 ;
- FIGS. 7A-7B are enlarged views of the tube seal
- FIGS. 8A-8D are drawings illustrating the principle of fluid transfer from tube to syringe due to positive pressure build up in the tube;
- FIGS. 9A-9D are drawings illustrating the principle of fluid transfer from tube to syringe due to pressure drop in the syringe;
- FIGS. 10A-10F depict a method for transferring at least one layer fluid from a collection tube 602 containing two or more layers of fluid
- FIGS. 11A-11J are drawings illustrating an example method with tube and regular syringes
- FIG. 12 is an enlarged view of the barrel of device 100 ;
- FIG. 13 is an enlarged view of the barrel seal of device 100 ;
- FIGS. 14A-14B are enlarged views of case of device 100 ;
- FIGS. 15A-15B are enlarged views of the cap 100 ;
- FIG. 16 is an exploded view of an example PRP device 100 ;
- FIGS. 17A-17B are views of the device 100 fully assembled
- FIGS. 18A-18H, 18I-1, 18I-2, 18J-1, 18J-2, 18K-1, 18K-2, 18L-1, 18L-2, and 18M are drawings illustrating an example method (with a tube and a barrel) of using device 100 ;
- FIGS. 19A-19E, 19F-1, 19F-2, 19G-1, 19G-2, 19H-1, 19H-2, 19I-1, and 19I-2 are drawings illustrating an example method (with a tube and barrels) of using device 100 ;
- FIGS. 20A, 20B-1, 20B-2, 20B-3, 20C-1, 20C-2, 20C-3, 20D-1, 20D-2, 20E-1, 20E-2 , 20 E- 1 , 20 E- 2 , 20 G- 1 , 20 G- 2 , 20 H- 1 , 20 H- 2 , 20 I- 1 , 20 I- 2 , 20 J- 1 , 20 J- 2 , 20 K- 1 , 20 K- 2 , 20 L- 1 , 20 L- 2 , and 20 M are drawings illustrating an example method (syringe and barrels) of using device 100 ;
- FIG. 21 shows the syringe connector being coupled with the tube seal
- FIG. 22 shows the assembled connector and tube seal being inserted into collection tube 602 ;
- FIGS. 23-24 show a syringe 180 before and after being coupled with the assembly of the collection tube with the connector and tube seal;
- FIG. 25 shows the connector and collection tube of FIG. 24 coupled with syringe 180 after the plasma and buffy coat (Platelet enriched plasma “PEP”) have been transferred; and
- FIG. 26 shows the syringe 180 of FIG. 25 after it has been disconnected from the connector 200 .
- Described herein is a tube seal and a barrel, which may be used to facilitate the removal of fluid layers having different density.
- the examples disclosed herein are described with reference to centrifuging whole blood in order to separate it into its constituent components, each of which has a different density.
- the invention is not limited to the constituent layers of whole blood.
- the invention can be used in situations/applications when a particular fraction of fluid has to be removed and transferred from one specimen tube to another syringe.
- the invention may be used in the process of obtaining adipose derived tissue stromal vascular fraction (AD-tSVF) from a body's fat aspirate, after emulsification and separation into density layers by centrifugation.
- AD-tSVF adipose derived tissue stromal vascular fraction
- the tube seal may be sized to fit commercially available fluid collection tubes.
- FIG. 3A shows the tube seal 108 of the present invention inserted into a conventional fluid collection tube 602 .
- FIG. 3B shows the tube seal 108 inserted into a conventional fluid collection tube 602 with an anticoagulant
- FIG. 3C shows the tube seal 108 inserted into a conventional fluid collection tube 602 with both an anticoagulant and a separating gel.
- FIG. 4A shows how the tube seal 108 is mounted on a distal end of a conventional syringe 180 .
- FIG. 4B shows how the syringe 180 , with the tube seal 108 mounted on a distal end thereof, is inserted into the mouth of a conventional fluid collection tube 602 .
- FIGS. 4C, 4D show the syringe 180 with the tube seal 108 mounted on a distal end thereof being moved distally within the conventional fluid collection tube 602 until a portion of the fluid within the fluid collection tube 602 is transferred into the syringe 180 .
- a tube seal dispenser to insert the tube seal into the fluid collection tube 602 instead of manually placing the tube seal in the tube with one's hand, or mounting the tube seal on the distal end of the syringe 180 .
- a method of using a dispenser to insert the tube seal into the fluid collection tube 602 using a dispenser is shown in FIGS. 5A-5D .
- FIG. 5A shows how the tube seal 108 is mounted on a distal end of a dispenser rod.
- FIG. 5B shows how the dispenser rod with the tube seal 108 mounted on a distal end thereof is inserted into the mouth of a conventional fluid collection tube 602 .
- FIGS. 5C, 5D show how the syringe 180 is placed in abutment or engagement with the tube seal inside of the fluid collection tube 602 , and how the syringe is moved distally within the conventional fluid collection tube 602 until a portion of the fluid within the fluid collection tube 602 is transferred into the syringe 180 .
- the tube seal 108 ( FIGS. 7A, 7B ) has a proximal end face 108 P and a distal end face 108 D.
- the end face 108 P, 108 D may have a shape 108 - 2 , 108 - 3 configured to compliment or mattingly engage the tapered end face of a conventional syringe.
- the tube seal 108 may be formed of resilient, elastomeric material such as rubber.
- An outer surface of the tube seal 108 may have a shape which mirrors the shape of the inner surface of the fluid collection tube thereby ensuring sealing engagement therebetween.
- one or more raised sealing rings 108 S spanning the outer circumference (surface) of the tube seal may be provided.
- the fluid collection tube 602 and the tube seal 108 each have a circular cross-section; however, these components may have any complimentary shaped cross-section.
- the tube seal 108 has a lumen 108 L.
- the lumen 108 L has a dual taper with a first taper 108 - 1 extending from the proximal end face 108 P towards the distal end face 108 D and a second taper 108 - 2 extending from the distal end face 108 D towards the proximal end face 108 P. See, FIG. 7B .
- the inner wall of the tube seal 108 which bounds or surrounds the lumen may be tapered. In the example depicted in FIG. 7B , the inner wall is tapered such that the lumen 108 L is wider at proximal end 108 P than at distal end 108 D.
- the inner wall may have a dual taper as desired.
- the tube seal 108 may be formed of an elastomeric material.
- the proximal end of the tube seal 108 is of a conical or funnel shape to direct any residual blood through the lumen 108 L to the other side of the tube seal 108 .
- the tube seal 108 is sized to sealingly engage the inner surface of a fluid collection tube.
- An outer surface of the tube seal 108 may have a shape which mirrors the shape of the inner surface of the fluid collection tube thereby ensuring sealing engagement therebetween.
- proximal end face 108 P of the tube seal 108 may have a shape which compliments or mattingly engages the tapered end face of the barrel 106 .
- the proximal end of the tube seal 108 is of a conical or funnel shape to direct any residual blood through the lumen 108 L to the other side of the tube seal 108 .
- the tube seal 108 may be provided by itself or as part of a kit or assembly.
- the kit may include a fluid collection tube, cap for fluid collection tube, and tube seal.
- the fluid collection tube will be prefilled with an anticoagulant.
- the fluid collection tube will be prefilled with an anticoagulant and a separating gel.
- the tube seal is preloaded into the fluid collection tube.
- the kit may include a dispenser for introducing the tube seal into the tube.
- the tube seal may also be pre-mounted on the tip of a conventional syringe or any syringe-like device.
- syringe or syringe-like device should be understood to encompass any conventional syringe having a plunger slidingly received within a tubular barrel.
- the plunger includes an elastomeric member on a distal end thereof which sealingly engages with the interior circumference of the tubular barrel.
- the syringe may be used to either inject fluid by advancing the plunger distally, or to aspirate fluids by retracting the plunger proximally.
- the tube seal 108 may be used as a connector and adapter for transferring fluids between a fluid collection tube and a syringe, and provides a fluidic connection between the tube and the syringe.
- the tube seal facilitates fluid transfer from the tube to the syringe due to a pressure rise in the tube (caused by advancing the syringe distally and exerting a pressure against the tube seal) FIGS. 8A-8D .
- FIG. 8A shows a fluid collection tube 602 containing a volume V 1 of fluid (at ambient pressure A), a tube seal 108 and a syringe 180 .
- FIG. 8B shows the fluid collection tube 602 and the syringe 180 of FIG.
- FIG. 8A shows the syringe 180 after the syringe 180 has been advanced distally into the fluid collection tube 602 thereby increasing the pressure of the volume of fluid V 1 (in the moment before fluid is transferred into the syringe due to the pressure gradient therebetween).
- FIG. 8C shows the fluid collection tube 602 and syringe 180 of FIG. 8B after a volume V 2 has been transferred from the fluid collection tube 602 to the syringe 180 due to the pressure gradient therebetween (in the moment before the pressure in the fluid collection tube 602 goes back to ambient.
- FIG. 8D shows the fluid collection tube 602 and syringe 180 of FIG. 8C after a volume V 2 has been transferred from the fluid collection tube 602 to the syringe 180 due to the pressure gradient therebetween, after the pressure in the fluid collection tube 602 goes back to ambient.
- FIG. 9A shows a fluid collection tube 602 containing a volume V 1 of fluid (at ambient pressure A), a tube seal 108 and a syringe 180 .
- FIG. 9B shows the fluid collection tube 602 and the syringe 180 of FIG. 9A after the plunger of syringe 180 has been retracted proximally thereby decreasing the pressure within the syringe 180 below ambient (in the moment before fluid is transferred into the syringe due to the pressure gradient therebetween).
- FIG. 9A shows a fluid collection tube 602 containing a volume V 1 of fluid (at ambient pressure A), a tube seal 108 and a syringe 180 .
- FIG. 9B shows the fluid collection tube 602 and the syringe 180 of FIG. 9A after the plunger of syringe 180 has been retracted proximally thereby decreasing the pressure within the syringe 180 below ambient (in the moment before fluid is transferred into the syringe due to the pressure
- FIG. 9C shows the fluid collection tube 602 and syringe 180 of FIG. 9B after a volume V 2 has been transferred from the fluid collection tube 602 to the syringe 180 due to the pressure gradient therebetween (in the moment before the pressure in the syringe 180 goes back to ambient.
- FIG. 9D shows the fluid collection tube 602 and syringe 180 of FIG. 9C after a volume V 2 has been transferred to the fluid collection tube 602 to the syringe 180 due to the pressure gradient therebetween, after the pressure in the syringe 180 goes back to ambient.
- FIGS. 10A-10F a method for transferring at least one layer fluid from a collection tube 602 containing two or more layers of fluid, where each layer of fluid has a different specific gravity will be explained.
- the generic process used to transfer fluid from a fluid collection tube 602 to a syringe 180 utilizing the tube seal 108 will be explained.
- a fluid collection tube 602 containing a fluid specimen is centrifuged to separate the fluid specimen into its constituent components by density: layer 1 , layer 2 , and layer 3 .
- density layer 1 , layer 2 , and layer 3 .
- cap 602 C is removed from the fluid collection tube 602 , and tube seal 108 is inserted into the mouth of the fluid collection tube 602 .
- tube seal 108 may be inserted into the fluid collection tube 602 prior to the centrifuging step illustrated in FIG. 10A .
- the fluid collection tube 602 may be equipped or supplied with the tube seal already inside the tube prior to insertion of the fluid.
- a syringe 180 (without a needle) is inserted into the mouth of the fluid collection tube 602 such that the distal tip of the syringe 180 is placed in sealing engagement with the tube seal 108 .
- the syringe 180 containing fluid 1 may be removed from the tube seal 108 upon the transfer or displacement of the desired quantity of fluid 1 .
- the syringe 180 may be removed from the tube seal 108 and at any time, and a new syringe or syringe-like device 180 may be introduced to transfer desired quantities of the remaining fluids 1 , 2 , 3 .
- FIGS. 11A-11J a method for transferring fluid from a fluid collection tube 602 to a syringe 180 utilizing the tube seal 108 will be explained.
- the example process pertains to the creation of platelet rich plasma but one of ordinary skill in the art will appreciate that the tube seal may be used generally to facilitate fluid transfer.
- a fluid collection tube 602 containing a specimen of whole blood is centrifuged to separate the whole blood into its constituent components by density: red blood cells (RBC), buffy coat, and plasma.
- RBC red blood cells
- cap 602 C is removed from the fluid collection tube 602 , and tube seal 108 is inserted into the mouth of the fluid collection tube 602 .
- tube seal 108 may be inserted into the fluid collection tube prior to the centrifuging step illustrated in FIG. 11A .
- the tube may be equipped or supplied with the tube seal already inside the tube prior to fluid collection.
- a syringe 180 (without a needle) is inserted into the mouth of the fluid collection tube 602 such that the distal tip of the syringe 180 is placed in sealing engagement with the tube seal 108 .
- FIG. 11E as the syringe 180 is advanced distally into the fluid collection tube 602 , plasma is displaced from the fluid collection tube 602 into the syringe 180 until between 2 ⁇ 3 and 3 ⁇ 4 (by volume) of the plasma is transferred into the syringe.
- the tube seal 108 seals the fluid collection tube 602 with the syringe, enabling the transfer of fluid.
- the plunger of the syringe 180 may be retracted instead of or in addition to advancing the syringe 180 distally into the fluid collection tube 602 .
- the syringe 180 and the tube seal 108 are advanced distally such that the remaining plasma and the buffy coat (collectively PRP) are transferred into the syringe 180 .
- the tube seal 108 seals the fluid collection tube 602 and the syringe 180 , enabling the transfer of fluid.
- the plunger of the syringe 180 may be retracted instead of or in addition to advancing the syringe 180 distally into the fluid collection tube 602 .
- FIGS. 11I and 11J the syringe 180 with the PRP is withdrawn from the fluid collection tube 602 , and a needle is attached to the syringe.
- the aforementioned process using the tube seal 108 is an improvement over the conventional process for creating PRP, because it eliminates the needles, eliminates separating gel, and does not solely rely on aspiration.
- kits for obtaining PRP using the tube seal 108 , as well as associated methods for separating platelet rich plasma (“PRP”) from whole blood.
- PRP platelet rich plasma
- the system, kit, and associated methods of the present invention address several shortcomings of conventional PRP kits in that it reduces the number of components needed, eliminates the need for a separating gel, in some examples enables separation of PRP from the tube after a single centrifuge spin cycle, eliminates the need for needles thereby reducing the risk of accidental needle stick, is simpler to use, and reduces the risk of sample contamination.
- the barrel 106 is a fluid transfer receptacle equipped with a piston-like barrel seal 108 .
- the barrel is sized to fit within the lumen of a standard fluid collection tube.
- the barrel features a tip, whose outer surface is capable of sealingly engaging with the tube seal, and an inner surface capable of sealingly engaging with a male Luer connector of a syringe.
- the below mentioned process using the tube seal 108 with the barrel 106 is an improvement over the conventional process for creating PRP, because while the tube seal eliminates the needles and separating gel and does not solely rely on aspiration, the barrel replaces both the transfer syringe and the second-spin tube.
- the barrel seal 108 may be formed of an elastomeric material which may be the same material used to form the tube seal.
- FIG. 12 The barrel 106 is an elongate hollow tube having sidewalls which surround a central lumen 106 L.
- a proximal end 106 P of the barrel is open and communicates with the lumen 106 L.
- a distal portion of the barrel gradually tapers narrower to a kind of Luer tip 106 T. In some examples the distal end 106 D is conical shaped.
- the tip 106 T tappers narrower.
- a width of the sidewall of the barrel 106 is less than gap G, and a diameter of lumen 106 L is greater than the diameter of the rod 103 .
- the distal end of the rod 103 fits into the proximal end of the barrel 106 and the rod 103 can be loosely inserted into the lumen 106 L.
- the barrel 106 may have the general appearance of a conventional syringe but in some examples differs from a conventional syringe in several key aspects.
- barrel 106 is not meant to be equipped with a needle.
- the outer side of the tip 106 T forms an oversized male to sealingly engage with a tube seal 108 , and cannot accommodate a needle.
- the inner side of the tip 106 T forms a female Luer connection configured to sealingly engage with a male Luer connection of a regular syringe.
- the proximal end 106 P of the barrel 106 lacks the flanges or gripping portions provided on conventional syringes which are used to assist advancing the plunger.
- the barrel 106 is never used to inject anything. Lacking a flange and without the plunger rod, the barrel 106 is configured to be securely received within a conventional centrifuge device.
- the barrel seal 104 ( FIGS. 13, 16 ) is movably provided within the lumen 106 L and will only move when pushed proximally by fluid entering the barrel 106 through the Luer tip 106 T or when advanced distally by the rod 103 .
- the rod 103 fits within lumen 106 L while the barrel 106 fits in the gap G between the rod 103 and the barrel 106 .
- the barrel cap 110 is an elongate hollow tube having a central lumen 110 L.
- a proximal end 110 P is open and communicates with the lumen 110 L, and distal end 110 D is closed.
- the barrel cap 110 includes a male plug 110 X attached to an inner surface thereof which is configured to sealingly engage the female aspects of the lumen of the tip 106 T.
- the barrel cap 110 includes a female plug 110 X which is configured to sealingly engage the exterior wall of the tip 106 T.
- FIGS. 17A, 17B show the device 100 fully assembled with the barrel seal 104 within the barrel 106 , the barrel 106 coaxially mounted over the rod 103 and received within the casing 102 , the tube seal 108 removably mounted on the tip 106 T, and the barrel cap 110 mounted over the tube seal 108 and a distal portion of the barrel 106 .
- the distal most part of the casing 102 overlaps the barrel cap 110
- FIG. 17B the distal most portion of the cap overlaps the distal most part of the casing 102 .
- FIG. 6 shows a fully assembled view and an exploded view of device 100 .
- the device 100 does not utilize needles to transfer the plasma and buffy coat out of the fluid collection tube 602 and eliminates the need for using a separating gel.
- FIG. 16 is an exploded view of an example device 100 which includes a casing 102 ( FIGS. 14A, 14B ) with its rod 103 , a barrel seal 104 ( FIG. 13 ), a barrel 106 ( FIG. 12 ), a tube seal 108 ( FIGS. 7A, 7B ) and a barrel cap 110 ( FIGS. 15A, 15B ).
- FIGS. 14A, 14B The casing 102 is an elongate hollow tube with a central lumen 102 L.
- proximal end 102 P of the casing 102 is closed, and distal end 102 D is open and communicates with the central lumen 102 L.
- a rod 103 is partially housed within the central lumen 102 L.
- a distal end 103 D extends beyond the distal end 102 D of the casing 102 .
- the distal end 102 D of the casing extends beyond the distal end 103 D of the rod 103 .
- the rod 103 is attached to the casing.
- a proximal end 103 P of the rod 103 may be attached to the proximal end 102 P of the casing 102 .
- the diameter of the lumen 102 L is greater than the diameter of the rod 103 such that a gap G is formed between an external surface of the rod 103 and an interior wall of the casing 102 .
- the rod 103 may be hollow or solid.
- the rod 103 serves to advance the barrel seal 104 ( FIGS. 13, 16 ) from a proximal end 106 P of the barrel 106 towards the distal end 106 D of the barrel.
- the barrel seal 104 may be formed of an elastomeric material and fluidically seals the inner surface or lumen 106 L of the barrel 106 .
- the barrel seal 104 abuts but is not attached to the rod 103 .
- retracting the rod 103 proximally will not retract the seal 104 .
- the seal 104 may be attached to the rod 103 .
- the rod 103 may have any shape and need not have a circular cross-section.
- the rod 103 must merely have sufficient structural integrity to advance the barrel seal 104 within the lumen 106 L.
- FIGS. 18A-18M illustrate steps in a method using device 100 . Some of the steps are optional, and the order in which the steps are described are not limiting.
- a fluid collection tube 602 containing whole blood which has been centrifuged to separate the whole blood into its constituent parts; namely, red blood cells, buffy coat and plasma.
- the tube cap 602 C is removed from the fluid collection tube 602 , and the casing 102 with the rod 103 are removed from the fully-assembled device 100 .
- FIG. 18C the barrel cap 110 is removed, exposing the tube seal 108 and the distal end of the barrel 106 .
- the distal end 106 D of the barrel 106 with the tube seal 108 are inserted into the fluid collection tube 602 .
- the distal end of the barrel 106 is gently removed with a twisting motion leaving the tube seal 108 engaged with the lumen of the fluid collection tube 602 .
- the proximal end of barrel 106 is placed in abutment with the tube seal 108 and is used to push or advance the tube seal 108 within the fluid collection tube until the tube seal just contacts the plasma.
- the proximal end 106 P of the barrel 106 is withdrawn, the barrel 106 is flipped, and the distal end 106 D is placed in sealing engagement with the tube seal 108 .
- FIG. 18G as the barrel 106 and tube seal 108 are advanced distally into the fluid collection tube 602 , plasma will flow proximally (in the opposite direction) through lumen 108 L into the hollow interior 106 H of the barrel 106 .
- the barrel seal 104 is pushed proximally by the fluid flowing into the barrel 106 .
- the barrel 106 should be advanced until red blood cells just start to enter into the barrel. At that point, plasma and the whole buffy coat have been transferred to the barrel 106 .
- the conical shape of the distal end of the tube seal 108 will preferentially move the outer part of the buffy coat to the center of the tube seal 108 before red blood cells start to enter the tip 106 T.
- the barrel 106 is withdrawn from the fluid collection tube 602 using a twisting and pulling motion to disengage the tube seal 108 from the barrel 106 .
- the tube seal 108 remains in the fluid collection tube 602 with the remaining red blood cells.
- the barrel cap 110 is engaged with the distal end 106 D of the barrel 106 .
- the barrel 106 containing the plasma and buffy coat (collectively PEP) is capped with device barrel cap 110 and centrifuged (second spin cycle) to separate the PEP into its constituent parts; namely, platelet poor plasma (PPP) on the top and platelet pallet (compacted platelets) proximate the barrel seal 104 .
- the centrifuged sample by volume comprises approximately 9/10 platelet poor plasma and 1/10 platelet pallet.
- a conventional syringe 180 is attached to the barrel 106 . More particularly, the male aspect of the syringe 180 interfaces with the female aspect of the barrel tip 106 T. In some examples, the rod 103 is inserted into the proximal end of the barrel 106 .
- the distal end of the rod 103 is advanced distally within the barrel lumen 106 L toward the tip 106 T pushing the barrel seal 104 distally and expelling any residual air out of the barrel first (ideally), and then transferring 2 ⁇ 3-3 ⁇ 4 of the platelets poor plasma (PPP) to the attached syringe 180 .
- PPP platelets poor plasma
- the plunger of the attached conventional syringe 180 may be retracted to affect the transfer of air and PPP.
- the conventional syringe 180 with air and the platelet poor plasma is disconnected from the barrel tip 106 T.
- FIGS. 18L-1 and 18L-2 an empty conventional syringe 180 is attached to the Luer tip 106 T.
- the platelet pallet and remaining plasma are transferred back-and-forth between the barrel 106 and the syringe 180 by alternatingly pushing the rod 103 and the syringe plunger of the conventional syringe 180 .
- This back-and-forth transfer dislodges the platelet pallet and mixes it with remaining plasma thereby creating platelet rich plasma (PRP). See, FIG. 18M .
- PRP platelet rich plasma
- FIGS. 20A-20M illustrate an example process for creating PRP.
- the barrel 106 is the key feature, because it integrates the functions of both the fluid collection tube and the tube seal.
- the fully assembled device 100 is disassembled by removing the barrel cap 110 , the tube seal 108 , case 102 and rod 103 from the barrel 106 , leaving the barrel seal 104 within the lumen of the tube 106 .
- FIGS. 20B-1, 20B-2 and 20B-3 a conventional syringe 180 containing whole blood is attached to the barrel 106 , and the blood is transferred from the syringe 180 into the barrel 106 by advancing the plunger within the syringe.
- the barrel seal 104 is pushed toward the proximal end 106 P of the barrel 106 by the blood entering the tube 106 .
- FIGS. 20C-1, 20C-2, and 20C-3 the now empty conventional syringe 108 is disengaged from the barrel 106 (and discarded), and the barrel cap 110 is placed in sealing engagement with the tip 106 T of the barrel 106 .
- the barrel 106 with the blood and the barrel cap 110 is centrifuged, separating the blood into a layer of red blood cells (RBC), buffy coat, and plasma.
- RBC red blood cells
- FIGS. 20E-1 and 20E-2 the barrel cap 110 is removed from the barrel 106 , and a fresh (empty) conventional syringe 180 having a plunger movably mounted within is placed in engagement with the tip 106 T of the barrel 106 .
- the plasma and buffy coat are transferred from the barrel 106 into the syringe 180 . This may be accomplished either by (a) retracting the plunger within the syringe 180 ; or (b) by advancing the rod 103 and the barrel seal 104 within the barrel 106 . Or both, as is the case with the tube.
- the red blood cells are not transferred from the barrel 106 into the syringe 180 .
- FIGS. 20G-1 and 20G-2 the syringe 180 with the PEP are connected to a fresh barrel 106 .
- the PEP is transferred from the syringe 180 into the barrel 106 , and barrel cap 110 is placed in sealing engagement with the barrel tip 106 T.
- the capped barrel 106 containing the PEP is centrifuged (second spin cycle) to separate the PEP into its constituent parts; namely, platelet poor plasma (PPP) on the top and platelet pallet (compacted platelets) proximate the barrel seal 104 .
- the centrifuged sample by volume comprises approximately 9/10 platelet poor plasma and 1/10 platelet pallet.
- a conventional syringe 180 is attached to the barrel 106 . More particularly, the male aspect of the syringe interfaces with the female aspect of the barrel tip 106 T. The rod 103 is inserted into the proximal end of the barrel 106 .
- the distal end of the rod 103 is advanced distally within the barrel lumen 106 L toward the tip 106 T pushing the barrel seal 104 distally and expelling any residual air and 2 ⁇ 3-3 ⁇ 4 of the platelets poor plasma (PPP) to the attached syringe 180 .
- PPP platelets poor plasma
- the plunger of the attached conventional syringe 180 may be retracted to affect the transfer of air and PPP.
- the conventional syringe 180 with air and the platelet poor plasma is disconnected from the barrel tip 106 T.
- the residual air could be expelled from the barrel prior to connecting the syringe 180 .
- FIGS. 20L-1 and 20L-2 an empty conventional syringe 180 is attached to the Luer tip 106 T.
- the platelet pallet and remaining plasma is transferred back-and-forth between the barrel 106 and the syringe 180 by alternatingly pushing the rod 103 and the syringe plunger of the conventional syringe 180 .
- This back-and-forth transfer is also applicable to the methods with the tube, that also use the barrel.
- This back-and-forth transfer dislodges platelet pallet and mixes it with remaining plasma thereby creating platelet rich plasma (PRP). See, FIG. 20M . Now the whole PRP is transferred to the conventional syringe 180 and is ready for use.
- PRP platelet rich plasma
- FIGS. 19A-19I-2 illustrate another example process for creating PRP.
- a fluid collection tube containing a sample of whole blood is centrifuged to separate the blood into constituent layers of red blood cells (RBC), buffy coat, and plasma.
- RBC red blood cells
- FIG. 19B the casing 102 and rod 103 are removed from the barrel 106 , and the cap 602 C is removed from the fluid collection tube 602 .
- the barrel cap 110 is removed from the barrel 106 , and the distal end of the barrel 106 with the barrel seal 104 inside the lumen of the barrel and the tube seal 108 mounted on the tip 106 T are inserted into the open mouth of a fluid collection tube 602 .
- the barrel is removed from the fluid collection tube with a gentle twisting motion to separate the tube seal 108 from the tip 106 T of the barrel 106 , leaving the tube seal 108 engaged with the inner surface of the fluid collection tube 602 .
- the barrel 106 is flipped and the proximal end 106 P is inserted into the fluid collection tube 602 and placed in abutment with the tube seal 108 .
- the barrel 106 is used to push the tube seal distally in the fluid collection tube until it comes in contact with the plasma.
- the proximal end of the barrel 106 is withdrawn, and the distal end of the barrel 106 is re-inserted into the sealing engagement with the fluid collection tube 602 .
- the barrel 106 is used to advance the tube seal 108 within the fluid collection tube 602 .
- plasma enters into the barrel and pushes the barrel seal 104 proximally.
- the barrel 106 is advanced until between 2 ⁇ 3 and 3 ⁇ 4 of the plasma has been transferred into the barrel 106 , leaving the red blood cells, buffy coat, and 1 ⁇ 4 of the plasma.
- the barrel with the plasma is disengaged from the fluid collection tube 602 and discarded.
- an empty barrel 106 is attached to the fluid collection tube 602 containing red blood cells, buffy coat, and remaining plasma.
- the barrel 106 is advanced into the fluid collection tube 602 until all of the plasma and the buffy coat are transferred into the barrel 106 , leaving the red blood cells.
- FIGS. 19H-1 and 19H-2 a fresh conventional syringe 180 is placed in sealing engagement with the tip 106 T of the barrel 106 containing the plasma and the buffy coat (collectively PRP).
- the plasma and buffy coat (PRP) are transferred from the barrel into the syringe by either (a) retracting the plunger within the syringe 180 ; or (b) by advancing the rod 103 and the barrel seal 104 within the barrel 106 .
- the barrel 106 is disconnected from the syringe and discarded, and a needle is attached to the syringe.
- FIG. 21 depicts an example of a syringe connector 200 which comprises an elongated tube having a lumen or through-hole 200 L extending between proximal and distal ends thereof.
- the connector 200 is formed of a transparent material which permits visualization of fluids within the through-hole 200 L.
- the proximal end is provided with a Luer-compatible female taper 200 P.
- a flange 200 F is provided proximate the distal end of connector 200 .
- Between the flange 200 F and the distal end of the connector 200 is a region 200 TS onto which the tube seal 108 is mounted.
- Flange 200 F limits the amount the tube seal 108 can be advanced along the distal end of the connector 200 .
- An outer diameter of the connector in the region 200 TS is sized to snugly (or sealingly) engage with the lumen or through-hole defined in the tube seal 108 .
- the distal end of connector 200 may in some examples also be provided with a Luer-compatible female taper 200 P.
- FIG. 22 shows the tube seal mounted onto the region 200 TS of the connector 200 about to be inserted into a specimen holder 602 containing a blood specimen which has been centrifuged thereby separating the blood specimen into distinct layers of RBC, buffy coat and plasma.
- FIG. 23 shows the connector of FIG. 22 advanced into the collection tube 602 and the plasma transferred from the collection tube 602 into the through-hole 200 L thereby de-airing the through-hole 200 L.
- Fluid is transferred from the specimen holder to the syringe 180 as the syringe 180 and connector 200 are advanced into the collection tube along with tube seal 108 .
- the tube seal 108 seals the collection tube such that the displaced fluid is transferred into the syringe 180 .
- FIG. 24 shows the connector and collection tube of FIG. 23 being coupled with syringe 180 .
- FIG. 25 shows the connector and collection tube of FIG. 24 coupled with syringe 180 after the plasma and buffy coat (platelet enriched plasma “PEP”) have been transferred from the collection tube 602 through connector 200 into the syringe 180 .
- plasma and buffy coat platelet enriched plasma “PEP”
- FIG. 26 shows the syringe 180 of FIG. 25 after it has been disconnected from the connector 200 .
Landscapes
- Health & Medical Sciences (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Clinical Laboratory Science (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Developmental Biology & Embryology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- External Artificial Organs (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Method for transferring one or more portions of fluid from a specimen tube, comprising: providing an elongate connector comprising an elongated tube having a lumen or through-hole extending between proximal and distal ends thereof, a Luer-compatible female taper provided on the proximal end of the connector, a flange provided proximate the distal end of the connector; providing a tube seal mounted on the distal end of the connector, the tube seal comprising an elastomeric member having a longitudinal axis, a proximal end, a distal end, and a through-hole extending therebetween, the distal end having a frustoconical or chamfered face forming a funnel, the elastomeric member having an outer diameter sized to sealingly engage with an inner surface of the specimen tube; advancing the distal end of the connector and the tube seal into the specimen tube, the funnel directing the first layer into the through-hole of the connector.
Description
- The invention relates to a method of needless fluid transfer from specimen collection tubes into syringes. The invention and the method have applications in biological, pharmaceutical, and medical fields where extraction of fluids and separation of fluid fractions take place. A preparation of platelet rich plasma (PRP) and separation of platelet poor plasma (PPP) from whole blood are just some of many uses for the device that employ the method of transfer described herein.
- Platelet Rich Plasma (PRP) is increasingly being used in various medical procedures as a catalyst for regeneration processes. PRP consists of blood plasma with concentrated platelets, which contain various growth factors and other cytokines that are known to stimulate regenerative processes of body tissues like bone, ligaments, skin, hair and much more. It is obtained from the patient's own blood after red blood cells (RBC) have been removed and the platelets are concentrated in a small volume of plasma to 4-8 times (or more) its normal count in blood.
- Platelet Poor Plasma (PPP) is used in many laboratory tests (including detecting antibodies in patient blood) and is obtained by removing from whole blood all cellular elements (red blood cells, platelets, white blood cells etc.).
- The central part in the process of PRP preparation is prompt separation of blood fractions. Undisturbed blood left alone will separate on its own, due to gravity forces into density layers, but usually a centrifuge is used to accelerate the process.
- Generic Process
- Traditionally PRP is obtained in several steps using a two-spin method. In the first step the patient's whole blood is drawn to a fluid collection tube. See,
FIGS. 1A and 1B . Next, the tube undergoes a first spin cycle (hereinafter “first spin”) in the centrifuge and the whole blood is separated into three broad fractions: red blood cells (RBC), buffy coat (leukocytes and platelets) and plasma. See,FIG. 1C . - In the next step, the buffy coat and plasma, collectively Platelet Enriched Plasma (PEP), which contains slightly concentrated platelets (up to two times normal blood count) are transferred to a second tube (
FIG. 1D ) for a second spin to further concentrate the platelets. After the second spin cycle (hereinafter “second spin”) the PEP will separate into Platelet Pallet (PP) and plasma with very few (substantially no) platelets called Platelet Poor Plasma (PPP). See,FIG. 1E . - In the final step, about two-thirds to three-quarters (⅔-¾) of PPP is removed. It contains essentially no cellular elements and can be used in various laboratory tests. The remaining plasma is mixed with Platelet Pallet. The resulting mixture is called PRP with platelet concentration of 4-8 (or more) times normal blood count. See,
FIG. 1F . - Prior Art Shortcomings
- After the first spin in the above-described process, a syringe is used to aspirate the plasma and buffy coat through a needle, in order to transfer both into a second tube for a second spin. However, in order to reach the buffy coat located just above the RBC, a small diameter syringe and/or a long needle, are required. Most importantly, it is very difficult to aspirate all buffy coat (layered on top of RBC), without also aspirating a significant quantity of the undesired RBC.
- Most commonly, commercial PRP tubes containing separating gel, are used to collect blood. See,
FIGS. 2A and 2B . While this PRP preparation process is somewhat easier, it also is more costly. The separating gel acts as a semi-permeable membrane. During centrifugation, RBC is forced to pass through the gel and collects beneath it, which leaves plasma and buffy coat physically separated above it. After centrifugation, the gel functions as a barrier, allowing the tube to be tilted or turned up-side down (to facilitate aspiration of the buffy coat and plasma), without causing the RBC to mix with the buffy coat and plasma. The mixture of buffy coat and plasma is called Platelets Enriched Plasma (PEP). In the next step, a syringe is used to aspirate the PEP through a needle, in order to transfer it into a second tube to undergo a second spin. See,FIGS. 2C and 2D . - Regardless of whether tubes with separating gel are used, after the first spin plasma and buffy coat (PEP) need to be transferred to another tube for a second spin, to further concentrate the platelets. Because of the relative complexity of those additional steps involved, the medical practitioners often choose to settle for PEP in their procedures, or in some cases proceed with the suboptimal PRP obtained by removing the excess plasma from the single spin.
- Present Invention Benefits
- The present invention addresses the shortcomings of the existing methods for transferring fluid density layers from specimen tubes into syringes. With respect to PRP preparation, it is a system which makes it possible to transfer a chosen layer of blood fraction after centrifugation, from a fluid collection tube to a syringe or a syringe-like receptacle, without the need for needles and without relying solely on negative pressure aspiration.
- The present invention also eliminates the need for separating gel, because it allows a precise transfer of plasma and buffy coat to a syringe or syringe-like device, with minimal RBC contamination. This is possible because the transfer of the lightest density fluid, which has a tendency to stay on top of heavier density fluids, always takes place first, and the quantity being transferred can be easily controlled.
- Eliminating the separating gel also eliminates the possibility of contaminating the plasma with gel particles; it also significantly reduces the cost to the operator as well as to the patient. Elimination of needles diminishes the risk of sample contamination and the risk of accidental needle poke that could lead to the transmission of infectious diseases (bacteria, viruses) to the operator.
- In addition to eliminating the needles, the present invention also eliminates the need for a second fluid collection tube and for the transfer syringe (used to transfer the product of the first spin (PEP) from the first tube into the second tube to perform the second spin).
- The core parts of the invention are a tube seal and a barrel, both of which allow transfer (or extraction) of the plasma (PPP/PEP) from the tube, without use of needles, directly into the barrel, eliminating error associated with precisely positioning the needle within a thin layer of buffy coat. The barrel, having diameter allowing it to be advanced into the tube, is serving as a perfect receptacle for acquiring the specimen from the tube, and having no flanges is perfect for insertion into the centrifuge. After the second spin, the barrel featuring a female Luer tip (Luer taper), allows easy transfer of plasma directly into the injection syringe, without need for connectors.
- In contrast, the conventional preparation of PEP/PRP with blood drawn into the tube, normally ends right after the first centrifugation with end result being PEP or an inferior single-spin PRP, the present invention allows the continuation of the process to the second centrifugation to obtain optimal two-spin PRP.
- Example 1: A method for transferring one or more portions of fluid from a specimen tube, comprising:
- providing a specimen tube containing a fluid specimen;
- centrifuging the specimen tube to separate the fluid specimen into at least a first layer having a density D1 and a second layer having a density D2 such that D2>D1;
- providing an elongate connector, where the connector comprises an elongated tube having a lumen or through-hole extending between proximal and distal ends thereof, a Luer-compatible female taper provided on the proximal end of the connector, a flange provided proximate the distal end of the connector;
- providing a tube seal mounted on the distal end of the connector, the tube seal comprising an elastomeric member having a longitudinal axis, a proximal end, a distal end, and a through-hole extending therebetween, the distal end having a frustoconical or chamfered face forming a funnel, the elastomeric member having an outer diameter sized to sealingly engage with an inner surface of the specimen tube;
- advancing the distal end of the connector and the tube seal into the specimen tube, the funnel directing the first layer into the through-hole of the connector, wherein the distal end of the connector and the tube seal are advanced until the first layer at least partially fills the comprises, through-hole of the connector, thereby de-airing the connector;
- providing a first syringe and connecting the first syringe to the female taper of the connector; and
- advancing the distal end of the connector and the tube seal and the connected first syringe into the specimen tube until the first layer is transferred into the first syringe.
- Example 2: The method of Example 1 wherein the distal end of connector is provided with a Luer-compatible male or female taper.
- Example 3: The method of Example 1, wherein:
- the fluid specimen is blood;
- the step of centrifuging the specimen tube separates the blood into a layer of plasma, a layer of buffy coat, and a layer of RBC, wherein the plasma has a density D1, the buffy coat has a density D2 and the RBC has a density D3 such that D3>D2>D1;
- advancing the distal end of the connector and the tube seal and the connected first syringe into the specimen tube until the plasma or the plasma and buffy coat are transferred into the first syringe.
- Example 4: The method of Example 3, wherein
- before the step of providing the first syringe, providing a second syringe and connecting the second syringe to the female taper of the connector;
- advancing the distal end of the connector and the tube seal and the connected second syringe into the specimen tube until between ½ and ¾ of the plasma is transferred into the second syringe; and
- disconnecting the second syringe.
- Example 5: A connector, comprising:
- an elongate tubular member having a proximal end, a distal end, and a lumen or through-hole extending therebetween, the tubular member formed of at least partially of a transparent or semi-transparent material;
- a first Luer-compatible female taper provided on the proximal end of the connector; and
- a flange provided proximate the distal end of the connector.
- Example 6: The connector of Example 5, a second Luer-compatible male or female taper provided on the distal end of the connector.
- Example 7: The connector of Example 5 further comprising a tube seal mounted on the distal end of the connector, the tube seal including an elastomeric member having a longitudinal axis, a proximal end, a distal end, and a through-hole extending therebetween, the distal end having a frustoconical or chamfered face forming a funnel, the elastomeric member having an outer diameter sized to sealingly engage with an inner surface of a specimen tube.
- Example 8: A method for transferring one or more portions of fluid from a specimen tube into a syringe, comprising:
- providing a specimen tube containing a tube seal and a fluid specimen, wherein tube seal includes an elastomeric member having a longitudinal axis, a proximal end, a distal end, and a through-hole extending therebetween, the distal end having a frustoconical or chamfered face forming a funnel, the elastomeric member having an outer diameter sized to sealingly engage with an inner surface of the specimen tube;
- centrifuging the specimen tube to separate the fluid specimen into at least a first and a second layer of fluid, where the first layer of fluid has a density D1 and the second layer of fluid has a density D2 such that D2>D1;
- providing an elongate connector, where the connector comprises an elongated tube having a lumen or through-hole extending between proximal and distal ends thereof, a Luer-compatible female taper provided on the proximal end of the connector, a flange provided proximate the distal end of the connector;
- advancing the distal end of the connector into the specimen tube such that the distal end of the connector fluidically couples with a proximal end of the tube seal, the funnel directing the first layer of fluid into the through-hole of the connector, wherein the distal end of the connector and the tube seal are advanced until the first layer of fluid fills the through-hole of the connector, thereby de-airing the connector;
- providing a first syringe and connecting the first syringe to the female taper of the connector; and
- advancing the distal end of the connector and the tube seal and the connected first syringe into the specimen tube until the first layer of fluid is transferred into the first syringe.
- Example 9: A method for making platelet enriched plasma, comprising:
- providing a specimen tube containing a centrifuged specimen of blood containing distinct layers of plasma, buffy coat and RBC;
- providing an elongate connector, where the connector comprises an elongated tube having a lumen or through-hole extending between proximal and distal ends thereof, a Luer-compatible female taper provided on the proximal end of the connector, a flange provided proximate the distal end of the connector;
- providing a tube seal mounted on the distal end of the connector, the tube seal comprising an elastomeric member having a longitudinal axis, a proximal end, a distal end, and a through-hole extending therebetween, the distal end having a frustoconical or chamfered face forming a funnel, the elastomeric member having an outer diameter sized to sealingly engage with an inner surface of the specimen tube;
- advancing the distal end of the connector and the tube seal into the specimen tube, the funnel directing the plasma into the through-hole of the connector, wherein the distal end of the connector is advanced until the plasma at least partially fills the comprises, through-hole of the connector, thereby de-airing the connector;
- providing a first syringe and connecting the first syringe to the female taper of the connector; and
- advancing the distal end of the connector and the connected first syringe into the specimen tube until the plasma and buffy coat are transferred into the first syringe.
-
FIG. 1A shows a fluid collection tube with anticoagulant; -
FIG. 1B shows the fluid collection tube ofFIG. 1A with a sample of whole blood; -
FIG. 1C shows the fluid collection tube ofFIG. 1B after it has been centrifuged -
FIG. 1D shows a fluid collection tube ofFIG. 1C containing plasma and buffy coat after the red blood cells have been removed; -
FIG. 1E shows the fluid collection tube ofFIG. 1D after it has been centrifuged -
FIG. 1F shows the fluid collection tube ofFIG. 1E after ¾ of the plasma has been removed leaving ¼ of the plasma and the platelet pallet (collectively PRP) -
FIG. 2A depicts a fluid collection tube containing separating gel and anti-coagulant -
FIG. 2B depicts the fluid collection tube ofFIG. 2A with a sample of whole blood -
FIG. 2C depicts the fluid collection tube ofFIG. 2B after it has been centrifuged -
FIG. 2D shows a syringe attached to the fluid collection tube ofFIG. 2C -
FIGS. 3A-3C are drawings illustrating examples of the tube seal in a fluid collection tube; -
FIGS. 4A-4D show a needleless transfer method for transferring fluid from a fluid collection tube into a syringe using the tube seal -
FIGS. 5A-5D show a method for inserting a tube seal into a fluid collection tube using a dispenser; -
FIG. 6 shows a fully assembled view and an exploded view ofdevice 100; -
FIGS. 7A-7B are enlarged views of the tube seal; -
FIGS. 8A-8D are drawings illustrating the principle of fluid transfer from tube to syringe due to positive pressure build up in the tube; -
FIGS. 9A-9D are drawings illustrating the principle of fluid transfer from tube to syringe due to pressure drop in the syringe; -
FIGS. 10A-10F depict a method for transferring at least one layer fluid from acollection tube 602 containing two or more layers of fluid -
FIGS. 11A-11J are drawings illustrating an example method with tube and regular syringes; -
FIG. 12 is an enlarged view of the barrel ofdevice 100; -
FIG. 13 is an enlarged view of the barrel seal ofdevice 100; -
FIGS. 14A-14B are enlarged views of case ofdevice 100; -
FIGS. 15A-15B are enlarged views of thecap 100; -
FIG. 16 is an exploded view of anexample PRP device 100; -
FIGS. 17A-17B are views of thedevice 100 fully assembled; -
FIGS. 18A-18H, 18I-1, 18I-2, 18J-1, 18J-2, 18K-1, 18K-2, 18L-1, 18L-2, and 18M are drawings illustrating an example method (with a tube and a barrel) of usingdevice 100; -
FIGS. 19A-19E, 19F-1, 19F-2, 19G-1, 19G-2, 19H-1, 19H-2, 19I-1, and 19I-2 are drawings illustrating an example method (with a tube and barrels) of usingdevice 100; and -
FIGS. 20A, 20B-1, 20B-2, 20B-3, 20C-1, 20C-2, 20C-3, 20D-1, 20D-2, 20E-1, 20E-2 , 20E-1, 20E-2, 20G-1, 20G-2, 20H-1, 20H-2, 20I-1, 20I-2, 20J-1, 20J-2, 20K-1, 20K-2, 20L-1, 20L-2, and 20M are drawings illustrating an example method (syringe and barrels) of usingdevice 100; -
FIG. 21 shows the syringe connector being coupled with the tube seal; -
FIG. 22 shows the assembled connector and tube seal being inserted intocollection tube 602; -
FIGS. 23-24 show asyringe 180 before and after being coupled with the assembly of the collection tube with the connector and tube seal; -
FIG. 25 shows the connector and collection tube ofFIG. 24 coupled withsyringe 180 after the plasma and buffy coat (Platelet enriched plasma “PEP”) have been transferred; and -
FIG. 26 shows thesyringe 180 ofFIG. 25 after it has been disconnected from theconnector 200. - Described herein is a tube seal and a barrel, which may be used to facilitate the removal of fluid layers having different density. The examples disclosed herein are described with reference to centrifuging whole blood in order to separate it into its constituent components, each of which has a different density. However, one of ordinary skill in the art will appreciate that the invention is not limited to the constituent layers of whole blood. For instance, the invention can be used in situations/applications when a particular fraction of fluid has to be removed and transferred from one specimen tube to another syringe. For example, the invention may be used in the process of obtaining adipose derived tissue stromal vascular fraction (AD-tSVF) from a body's fat aspirate, after emulsification and separation into density layers by centrifugation.
- The Tube Seal
- The tube seal may be sized to fit commercially available fluid collection tubes.
FIG. 3A shows thetube seal 108 of the present invention inserted into a conventionalfluid collection tube 602.FIG. 3B shows thetube seal 108 inserted into a conventionalfluid collection tube 602 with an anticoagulant,FIG. 3C shows thetube seal 108 inserted into a conventionalfluid collection tube 602 with both an anticoagulant and a separating gel. -
FIG. 4A shows how thetube seal 108 is mounted on a distal end of aconventional syringe 180. -
FIG. 4B shows how thesyringe 180, with thetube seal 108 mounted on a distal end thereof, is inserted into the mouth of a conventionalfluid collection tube 602. -
FIGS. 4C, 4D show thesyringe 180 with thetube seal 108 mounted on a distal end thereof being moved distally within the conventionalfluid collection tube 602 until a portion of the fluid within thefluid collection tube 602 is transferred into thesyringe 180. - In some examples it may be desirable to use a tube seal dispenser to insert the tube seal into the
fluid collection tube 602 instead of manually placing the tube seal in the tube with one's hand, or mounting the tube seal on the distal end of thesyringe 180. A method of using a dispenser to insert the tube seal into thefluid collection tube 602 using a dispenser is shown inFIGS. 5A-5D . -
FIG. 5A shows how thetube seal 108 is mounted on a distal end of a dispenser rod. -
FIG. 5B shows how the dispenser rod with thetube seal 108 mounted on a distal end thereof is inserted into the mouth of a conventionalfluid collection tube 602. -
FIGS. 5C, 5D show how thesyringe 180 is placed in abutment or engagement with the tube seal inside of thefluid collection tube 602, and how the syringe is moved distally within the conventionalfluid collection tube 602 until a portion of the fluid within thefluid collection tube 602 is transferred into thesyringe 180. - The tube seal 108 (
FIGS. 7A, 7B ) has aproximal end face 108P and adistal end face 108D. In some examples, theend face tube seal 108 may be formed of resilient, elastomeric material such as rubber. - An outer surface of the
tube seal 108 may have a shape which mirrors the shape of the inner surface of the fluid collection tube thereby ensuring sealing engagement therebetween. In some examples, one or more raised sealingrings 108S spanning the outer circumference (surface) of the tube seal may be provided. In the example shown inFIGS. 3A-3C , thefluid collection tube 602 and thetube seal 108 each have a circular cross-section; however, these components may have any complimentary shaped cross-section. - As best seen in
FIGS. 7A, 7B , thetube seal 108 has alumen 108L. In some examples, thelumen 108L has a dual taper with a first taper 108-1 extending from theproximal end face 108P towards thedistal end face 108D and a second taper 108-2 extending from thedistal end face 108D towards theproximal end face 108P. See,FIG. 7B . Additionally, the inner wall of thetube seal 108 which bounds or surrounds the lumen, may be tapered. In the example depicted inFIG. 7B , the inner wall is tapered such that thelumen 108L is wider atproximal end 108P than atdistal end 108D. The inner wall may have a dual taper as desired. Thetube seal 108 may be formed of an elastomeric material. - In some examples, the proximal end of the
tube seal 108 is of a conical or funnel shape to direct any residual blood through thelumen 108L to the other side of thetube seal 108. - The
tube seal 108 is sized to sealingly engage the inner surface of a fluid collection tube. An outer surface of thetube seal 108 may have a shape which mirrors the shape of the inner surface of the fluid collection tube thereby ensuring sealing engagement therebetween. - In some examples, the
proximal end face 108P of thetube seal 108 may have a shape which compliments or mattingly engages the tapered end face of thebarrel 106. - In some examples, the proximal end of the
tube seal 108 is of a conical or funnel shape to direct any residual blood through thelumen 108L to the other side of thetube seal 108. - The
tube seal 108 may be provided by itself or as part of a kit or assembly. The kit may include a fluid collection tube, cap for fluid collection tube, and tube seal. In some examples, the fluid collection tube will be prefilled with an anticoagulant. In some examples, the fluid collection tube will be prefilled with an anticoagulant and a separating gel. In some examples, the tube seal is preloaded into the fluid collection tube. In some examples, the kit may include a dispenser for introducing the tube seal into the tube. The tube seal may also be pre-mounted on the tip of a conventional syringe or any syringe-like device. - Throughout this disclosure, the term syringe or syringe-like device should be understood to encompass any conventional syringe having a plunger slidingly received within a tubular barrel. The plunger includes an elastomeric member on a distal end thereof which sealingly engages with the interior circumference of the tubular barrel. The syringe may be used to either inject fluid by advancing the plunger distally, or to aspirate fluids by retracting the plunger proximally.
- As will be explained below, the
tube seal 108 may be used as a connector and adapter for transferring fluids between a fluid collection tube and a syringe, and provides a fluidic connection between the tube and the syringe. In some examples the tube seal facilitates fluid transfer from the tube to the syringe due to a pressure rise in the tube (caused by advancing the syringe distally and exerting a pressure against the tube seal)FIGS. 8A-8D .FIG. 8A shows afluid collection tube 602 containing a volume V1 of fluid (at ambient pressure A), atube seal 108 and asyringe 180.FIG. 8B shows thefluid collection tube 602 and thesyringe 180 ofFIG. 8A after thesyringe 180 has been advanced distally into thefluid collection tube 602 thereby increasing the pressure of the volume of fluid V1 (in the moment before fluid is transferred into the syringe due to the pressure gradient therebetween).FIG. 8C shows thefluid collection tube 602 andsyringe 180 ofFIG. 8B after a volume V2 has been transferred from thefluid collection tube 602 to thesyringe 180 due to the pressure gradient therebetween (in the moment before the pressure in thefluid collection tube 602 goes back to ambient.FIG. 8D shows thefluid collection tube 602 andsyringe 180 ofFIG. 8C after a volume V2 has been transferred from thefluid collection tube 602 to thesyringe 180 due to the pressure gradient therebetween, after the pressure in thefluid collection tube 602 goes back to ambient. - In some examples the tube seal facilitates fluid transfer from the tube to the syringe due to a pressure drop in the connected syringe (caused by retracting the plunger proximally and creating suction in the syringe).
FIG. 9A shows afluid collection tube 602 containing a volume V1 of fluid (at ambient pressure A), atube seal 108 and asyringe 180.FIG. 9B shows thefluid collection tube 602 and thesyringe 180 ofFIG. 9A after the plunger ofsyringe 180 has been retracted proximally thereby decreasing the pressure within thesyringe 180 below ambient (in the moment before fluid is transferred into the syringe due to the pressure gradient therebetween).FIG. 9C shows thefluid collection tube 602 andsyringe 180 ofFIG. 9B after a volume V2 has been transferred from thefluid collection tube 602 to thesyringe 180 due to the pressure gradient therebetween (in the moment before the pressure in thesyringe 180 goes back to ambient.FIG. 9D shows thefluid collection tube 602 andsyringe 180 ofFIG. 9C after a volume V2 has been transferred to thefluid collection tube 602 to thesyringe 180 due to the pressure gradient therebetween, after the pressure in thesyringe 180 goes back to ambient. - Generic Process of Fluid Transfer
- Turning now to
FIGS. 10A-10F , a method for transferring at least one layer fluid from acollection tube 602 containing two or more layers of fluid, where each layer of fluid has a different specific gravity will be explained. The generic process used to transfer fluid from afluid collection tube 602 to asyringe 180 utilizing thetube seal 108 will be explained. - In
FIG. 10A , afluid collection tube 602 containing a fluid specimen is centrifuged to separate the fluid specimen into its constituent components by density:layer 1,layer 2, andlayer 3. One of ordinary skill in the art will appreciate that the method may be used with any number of different density fluid layers. - In
FIG. 10B ,cap 602C is removed from thefluid collection tube 602, andtube seal 108 is inserted into the mouth of thefluid collection tube 602. One of ordinary skill in the art will appreciate that thetube seal 108 may be inserted into thefluid collection tube 602 prior to the centrifuging step illustrated inFIG. 10A . Or thefluid collection tube 602 may be equipped or supplied with the tube seal already inside the tube prior to insertion of the fluid. - In
FIGS. 10C, 10D , a syringe 180 (without a needle) is inserted into the mouth of thefluid collection tube 602 such that the distal tip of thesyringe 180 is placed in sealing engagement with thetube seal 108. - In
FIG. 10E , as thesyringe 180 is advanced distally into thefluid collection tube 602,fluid 1 is displaced from thefluid collection tube 602 into thesyringe 180. Thetube seal 108 seals thefluid collection tube 602 with the syringe, enabling the transfer of fluid. It should be appreciated that the plunger of thesyringe 180 may be retracted instead of or in addition to advancing thesyringe 180 distally into thefluid collection tube 602. - If
FIG. 10F , thesyringe 180 containingfluid 1 may be removed from thetube seal 108 upon the transfer or displacement of the desired quantity offluid 1. One of ordinary skill will appreciate that thesyringe 180 may be removed from thetube seal 108 and at any time, and a new syringe or syringe-like device 180 may be introduced to transfer desired quantities of the remainingfluids - Turning now to
FIGS. 11A-11J , a method for transferring fluid from afluid collection tube 602 to asyringe 180 utilizing thetube seal 108 will be explained. The example process pertains to the creation of platelet rich plasma but one of ordinary skill in the art will appreciate that the tube seal may be used generally to facilitate fluid transfer. - In
FIG. 11A , afluid collection tube 602 containing a specimen of whole blood is centrifuged to separate the whole blood into its constituent components by density: red blood cells (RBC), buffy coat, and plasma. - In
FIG. 11B ,cap 602C is removed from thefluid collection tube 602, andtube seal 108 is inserted into the mouth of thefluid collection tube 602. One of ordinary skill in the art will appreciate that thetube seal 108 may be inserted into the fluid collection tube prior to the centrifuging step illustrated inFIG. 11A . Or the tube may be equipped or supplied with the tube seal already inside the tube prior to fluid collection. - In
FIGS. 11C, 11D , a syringe 180 (without a needle) is inserted into the mouth of thefluid collection tube 602 such that the distal tip of thesyringe 180 is placed in sealing engagement with thetube seal 108. - In
FIG. 11E , as thesyringe 180 is advanced distally into thefluid collection tube 602, plasma is displaced from thefluid collection tube 602 into thesyringe 180 until between ⅔ and ¾ (by volume) of the plasma is transferred into the syringe. Thetube seal 108 seals thefluid collection tube 602 with the syringe, enabling the transfer of fluid. It should be appreciated that the plunger of thesyringe 180 may be retracted instead of or in addition to advancing thesyringe 180 distally into thefluid collection tube 602. - In
FIG. 11F , thesyringe 180 with the plasma is discarded, and a fresh (empty)syringe 180 is placed into sealing engagement with thetube seal 108. - In
FIGS. 11G, 11H , thesyringe 180 and thetube seal 108 are advanced distally such that the remaining plasma and the buffy coat (collectively PRP) are transferred into thesyringe 180. Again, thetube seal 108 seals thefluid collection tube 602 and thesyringe 180, enabling the transfer of fluid. Also, the plunger of thesyringe 180 may be retracted instead of or in addition to advancing thesyringe 180 distally into thefluid collection tube 602. - In
FIGS. 11I and 11J , thesyringe 180 with the PRP is withdrawn from thefluid collection tube 602, and a needle is attached to the syringe. - The aforementioned process using the
tube seal 108 is an improvement over the conventional process for creating PRP, because it eliminates the needles, eliminates separating gel, and does not solely rely on aspiration. - Also disclosed is a system and kit for obtaining PRP using the
tube seal 108, as well as associated methods for separating platelet rich plasma (“PRP”) from whole blood. The system, kit, and associated methods of the present invention address several shortcomings of conventional PRP kits in that it reduces the number of components needed, eliminates the need for a separating gel, in some examples enables separation of PRP from the tube after a single centrifuge spin cycle, eliminates the need for needles thereby reducing the risk of accidental needle stick, is simpler to use, and reduces the risk of sample contamination. - The Barrel
- As will be explained below, the
barrel 106 is a fluid transfer receptacle equipped with a piston-like barrel seal 108. The barrel is sized to fit within the lumen of a standard fluid collection tube. The barrel features a tip, whose outer surface is capable of sealingly engaging with the tube seal, and an inner surface capable of sealingly engaging with a male Luer connector of a syringe. The below mentioned process using thetube seal 108 with thebarrel 106, is an improvement over the conventional process for creating PRP, because while the tube seal eliminates the needles and separating gel and does not solely rely on aspiration, the barrel replaces both the transfer syringe and the second-spin tube. - The
barrel seal 108 may be formed of an elastomeric material which may be the same material used to form the tube seal. -
FIG. 12 : Thebarrel 106 is an elongate hollow tube having sidewalls which surround acentral lumen 106L. Aproximal end 106P of the barrel is open and communicates with thelumen 106L. A distal portion of the barrel gradually tapers narrower to a kind ofLuer tip 106T. In some examples thedistal end 106D is conical shaped. Thetip 106T tappers narrower. A width of the sidewall of thebarrel 106 is less than gap G, and a diameter oflumen 106L is greater than the diameter of therod 103. The distal end of therod 103 fits into the proximal end of thebarrel 106 and therod 103 can be loosely inserted into thelumen 106L. - The
barrel 106 may have the general appearance of a conventional syringe but in some examples differs from a conventional syringe in several key aspects. One notable difference is thatbarrel 106 is not meant to be equipped with a needle. The outer side of thetip 106T forms an oversized male to sealingly engage with atube seal 108, and cannot accommodate a needle. The inner side of thetip 106T forms a female Luer connection configured to sealingly engage with a male Luer connection of a regular syringe. Another notable difference is that theproximal end 106P of thebarrel 106 lacks the flanges or gripping portions provided on conventional syringes which are used to assist advancing the plunger. Thebarrel 106 is never used to inject anything. Lacking a flange and without the plunger rod, thebarrel 106 is configured to be securely received within a conventional centrifuge device. - The barrel seal 104 (
FIGS. 13, 16 ) is movably provided within thelumen 106L and will only move when pushed proximally by fluid entering thebarrel 106 through theLuer tip 106T or when advanced distally by therod 103. - As best seen in
FIGS. 17A, 17B therod 103 fits withinlumen 106L while thebarrel 106 fits in the gap G between therod 103 and thebarrel 106. - As best seen in
FIGS. 15A, 15B , thebarrel cap 110 is an elongate hollow tube having acentral lumen 110L. In some examples, aproximal end 110P is open and communicates with thelumen 110L, anddistal end 110D is closed. InFIG. 15A , thebarrel cap 110 includes amale plug 110X attached to an inner surface thereof which is configured to sealingly engage the female aspects of the lumen of thetip 106T. InFIG. 15B , thebarrel cap 110 includes afemale plug 110X which is configured to sealingly engage the exterior wall of thetip 106T. -
FIGS. 17A, 17B show thedevice 100 fully assembled with thebarrel seal 104 within thebarrel 106, thebarrel 106 coaxially mounted over therod 103 and received within thecasing 102, thetube seal 108 removably mounted on thetip 106T, and thebarrel cap 110 mounted over thetube seal 108 and a distal portion of thebarrel 106. InFIG. 17A the distal most part of thecasing 102 overlaps thebarrel cap 110, whereas inFIG. 17B the distal most portion of the cap overlaps the distal most part of thecasing 102. -
FIG. 6 shows a fully assembled view and an exploded view ofdevice 100. - It should be noted that the
device 100 does not utilize needles to transfer the plasma and buffy coat out of thefluid collection tube 602 and eliminates the need for using a separating gel. -
FIG. 16 is an exploded view of anexample device 100 which includes a casing 102 (FIGS. 14A, 14B ) with itsrod 103, a barrel seal 104 (FIG. 13 ), a barrel 106 (FIG. 12 ), a tube seal 108 (FIGS. 7A, 7B ) and a barrel cap 110 (FIGS. 15A, 15B ). -
FIGS. 14A, 14B : The casing 102 is an elongate hollow tube with acentral lumen 102L. In some examples,proximal end 102P of thecasing 102 is closed, anddistal end 102D is open and communicates with thecentral lumen 102L. Arod 103 is partially housed within thecentral lumen 102L. InFIG. 14A , adistal end 103D extends beyond thedistal end 102D of thecasing 102. InFIG. 14B , thedistal end 102D of the casing extends beyond thedistal end 103D of therod 103. In some examples, therod 103 is attached to the casing. For example, aproximal end 103P of therod 103 may be attached to theproximal end 102P of thecasing 102. The diameter of thelumen 102L is greater than the diameter of therod 103 such that a gap G is formed between an external surface of therod 103 and an interior wall of thecasing 102. - The
rod 103 may be hollow or solid. Therod 103 serves to advance the barrel seal 104 (FIGS. 13, 16 ) from aproximal end 106P of thebarrel 106 towards thedistal end 106D of the barrel. Thebarrel seal 104 may be formed of an elastomeric material and fluidically seals the inner surface orlumen 106L of thebarrel 106. In some examples, thebarrel seal 104 abuts but is not attached to therod 103. In this example, once therod 103 has advanced theseal 104 distally, retracting therod 103 proximally will not retract theseal 104. However, in other examples, theseal 104 may be attached to therod 103. - The
rod 103 may have any shape and need not have a circular cross-section. Therod 103 must merely have sufficient structural integrity to advance thebarrel seal 104 within thelumen 106L. -
FIGS. 18A-18M illustrate steps in amethod using device 100. Some of the steps are optional, and the order in which the steps are described are not limiting. - In
FIG. 18A , afluid collection tube 602 containing whole blood which has been centrifuged to separate the whole blood into its constituent parts; namely, red blood cells, buffy coat and plasma. - In
FIG. 18B , thetube cap 602C is removed from thefluid collection tube 602, and thecasing 102 with therod 103 are removed from the fully-assembleddevice 100. - In
FIG. 18C , thebarrel cap 110 is removed, exposing thetube seal 108 and the distal end of thebarrel 106. Thedistal end 106D of thebarrel 106 with thetube seal 108 are inserted into thefluid collection tube 602. - In
FIG. 18D (optional), the distal end of thebarrel 106 is gently removed with a twisting motion leaving thetube seal 108 engaged with the lumen of thefluid collection tube 602. - In
FIG. 18E (optional), the proximal end ofbarrel 106 is placed in abutment with thetube seal 108 and is used to push or advance thetube seal 108 within the fluid collection tube until the tube seal just contacts the plasma. - In
FIG. 18F (optional), theproximal end 106P of thebarrel 106 is withdrawn, thebarrel 106 is flipped, and thedistal end 106D is placed in sealing engagement with thetube seal 108. - In
FIG. 18G , as thebarrel 106 andtube seal 108 are advanced distally into thefluid collection tube 602, plasma will flow proximally (in the opposite direction) throughlumen 108L into the hollow interior 106H of thebarrel 106. Thebarrel seal 104 is pushed proximally by the fluid flowing into thebarrel 106. Thebarrel 106 should be advanced until red blood cells just start to enter into the barrel. At that point, plasma and the whole buffy coat have been transferred to thebarrel 106. The conical shape of the distal end of thetube seal 108 will preferentially move the outer part of the buffy coat to the center of thetube seal 108 before red blood cells start to enter thetip 106T. - In
FIG. 18H , thebarrel 106 is withdrawn from thefluid collection tube 602 using a twisting and pulling motion to disengage thetube seal 108 from thebarrel 106. In other words, as thebarrel 106 is withdrawn, thetube seal 108 remains in thefluid collection tube 602 with the remaining red blood cells. Thebarrel cap 110 is engaged with thedistal end 106D of thebarrel 106. - In
FIGS. 18I-1 and 18I-2 , thebarrel 106 containing the plasma and buffy coat (collectively PEP) is capped withdevice barrel cap 110 and centrifuged (second spin cycle) to separate the PEP into its constituent parts; namely, platelet poor plasma (PPP) on the top and platelet pallet (compacted platelets) proximate thebarrel seal 104. The centrifuged sample by volume comprises approximately 9/10 platelet poor plasma and 1/10 platelet pallet. One of ordinary skill in the art will appreciate that when inserting the tubular barrel into the centrifuge, the tip of the barrel should be pointing to the center axis of rotation. - In
FIGS. 18J-1 and 18J-2 , aconventional syringe 180 is attached to thebarrel 106. More particularly, the male aspect of thesyringe 180 interfaces with the female aspect of thebarrel tip 106T. In some examples, therod 103 is inserted into the proximal end of thebarrel 106. - In
FIGS. 18K-1 and 18K-2 , the distal end of therod 103 is advanced distally within thebarrel lumen 106L toward thetip 106T pushing thebarrel seal 104 distally and expelling any residual air out of the barrel first (ideally), and then transferring ⅔-¾ of the platelets poor plasma (PPP) to the attachedsyringe 180. One of ordinary skill in the art will appreciate that instead of (or in addition to) advancing therod 103, the plunger of the attachedconventional syringe 180 may be retracted to affect the transfer of air and PPP. Theconventional syringe 180 with air and the platelet poor plasma is disconnected from thebarrel tip 106T. - In
FIGS. 18L-1 and 18L-2 , an emptyconventional syringe 180 is attached to theLuer tip 106T. The platelet pallet and remaining plasma are transferred back-and-forth between thebarrel 106 and thesyringe 180 by alternatingly pushing therod 103 and the syringe plunger of theconventional syringe 180. This back-and-forth transfer dislodges the platelet pallet and mixes it with remaining plasma thereby creating platelet rich plasma (PRP). See,FIG. 18M . Now the whole PRP is transferred to theconventional syringe 180 and is ready for use. -
FIGS. 20A-20M illustrate an example process for creating PRP. In this example, thebarrel 106 is the key feature, because it integrates the functions of both the fluid collection tube and the tube seal. - In
FIG. 20A the fully assembleddevice 100 is disassembled by removing thebarrel cap 110, thetube seal 108,case 102 androd 103 from thebarrel 106, leaving thebarrel seal 104 within the lumen of thetube 106. - In
FIGS. 20B-1, 20B-2 and 20B-3 aconventional syringe 180 containing whole blood is attached to thebarrel 106, and the blood is transferred from thesyringe 180 into thebarrel 106 by advancing the plunger within the syringe. Thebarrel seal 104 is pushed toward theproximal end 106P of thebarrel 106 by the blood entering thetube 106. - In
FIGS. 20C-1, 20C-2, and 20C-3 the now emptyconventional syringe 108 is disengaged from the barrel 106 (and discarded), and thebarrel cap 110 is placed in sealing engagement with thetip 106T of thebarrel 106. - In
FIGS. 20D-1 and 20D-2 , thebarrel 106 with the blood and thebarrel cap 110 is centrifuged, separating the blood into a layer of red blood cells (RBC), buffy coat, and plasma. - In
FIGS. 20E-1 and 20E-2 , thebarrel cap 110 is removed from thebarrel 106, and a fresh (empty)conventional syringe 180 having a plunger movably mounted within is placed in engagement with thetip 106T of thebarrel 106. - In
FIGS. 20E-1 and 20E-2 the plasma and buffy coat (collectively “PEP”) are transferred from thebarrel 106 into thesyringe 180. This may be accomplished either by (a) retracting the plunger within thesyringe 180; or (b) by advancing therod 103 and thebarrel seal 104 within thebarrel 106. Or both, as is the case with the tube. The red blood cells are not transferred from thebarrel 106 into thesyringe 180. - In
FIGS. 20G-1 and 20G-2 , thesyringe 180 with the PEP are connected to afresh barrel 106. - In
FIGS. 20H-1 and 20H-2 , the PEP is transferred from thesyringe 180 into thebarrel 106, andbarrel cap 110 is placed in sealing engagement with thebarrel tip 106T. - In
FIGS. 20I-1 and 20I-2 , the cappedbarrel 106 containing the PEP is centrifuged (second spin cycle) to separate the PEP into its constituent parts; namely, platelet poor plasma (PPP) on the top and platelet pallet (compacted platelets) proximate thebarrel seal 104. The centrifuged sample by volume comprises approximately 9/10 platelet poor plasma and 1/10 platelet pallet. - In
FIGS. 20J-1 and 20J-2 , aconventional syringe 180 is attached to thebarrel 106. More particularly, the male aspect of the syringe interfaces with the female aspect of thebarrel tip 106T. Therod 103 is inserted into the proximal end of thebarrel 106. - In
FIGS. 20K-1 and 20K-2 , the distal end of therod 103 is advanced distally within thebarrel lumen 106L toward thetip 106T pushing thebarrel seal 104 distally and expelling any residual air and ⅔-¾ of the platelets poor plasma (PPP) to the attachedsyringe 180. One of ordinary skill in the art will appreciate that instead of (or in addition to) advancing therod 103, the plunger of the attachedconventional syringe 180 may be retracted to affect the transfer of air and PPP. Theconventional syringe 180 with air and the platelet poor plasma is disconnected from thebarrel tip 106T. One of ordinary skill in the art will appreciate that the residual air could be expelled from the barrel prior to connecting thesyringe 180. - In
FIGS. 20L-1 and 20L-2 , an emptyconventional syringe 180 is attached to theLuer tip 106T. The platelet pallet and remaining plasma is transferred back-and-forth between thebarrel 106 and thesyringe 180 by alternatingly pushing therod 103 and the syringe plunger of theconventional syringe 180. This back-and-forth transfer is also applicable to the methods with the tube, that also use the barrel. This back-and-forth transfer dislodges platelet pallet and mixes it with remaining plasma thereby creating platelet rich plasma (PRP). See,FIG. 20M . Now the whole PRP is transferred to theconventional syringe 180 and is ready for use. -
FIGS. 19A-19I-2 illustrate another example process for creating PRP. - In
FIG. 19A , a fluid collection tube containing a sample of whole blood is centrifuged to separate the blood into constituent layers of red blood cells (RBC), buffy coat, and plasma. - In
FIG. 19B , thecasing 102 androd 103 are removed from thebarrel 106, and thecap 602C is removed from thefluid collection tube 602. - In
FIG. 19C , thebarrel cap 110 is removed from thebarrel 106, and the distal end of thebarrel 106 with thebarrel seal 104 inside the lumen of the barrel and thetube seal 108 mounted on thetip 106T are inserted into the open mouth of afluid collection tube 602. - In
FIG. 19D (optional), the barrel is removed from the fluid collection tube with a gentle twisting motion to separate thetube seal 108 from thetip 106T of thebarrel 106, leaving thetube seal 108 engaged with the inner surface of thefluid collection tube 602. - In
FIG. 19E (optional), thebarrel 106 is flipped and theproximal end 106P is inserted into thefluid collection tube 602 and placed in abutment with thetube seal 108. Thebarrel 106 is used to push the tube seal distally in the fluid collection tube until it comes in contact with the plasma. The proximal end of thebarrel 106 is withdrawn, and the distal end of thebarrel 106 is re-inserted into the sealing engagement with thefluid collection tube 602. - In
FIGS. 19F-1 and 19F-2 thebarrel 106 is used to advance thetube seal 108 within thefluid collection tube 602. As thebarrel 106 is advanced distally into thefluid collection tube 602, plasma enters into the barrel and pushes thebarrel seal 104 proximally. Thebarrel 106 is advanced until between ⅔ and ¾ of the plasma has been transferred into thebarrel 106, leaving the red blood cells, buffy coat, and ¼ of the plasma. The barrel with the plasma is disengaged from thefluid collection tube 602 and discarded. - In
FIGS. 19G-1 and 19G-2 , anempty barrel 106 is attached to thefluid collection tube 602 containing red blood cells, buffy coat, and remaining plasma. Thebarrel 106 is advanced into thefluid collection tube 602 until all of the plasma and the buffy coat are transferred into thebarrel 106, leaving the red blood cells. - In
FIGS. 19H-1 and 19H-2 a freshconventional syringe 180 is placed in sealing engagement with thetip 106T of thebarrel 106 containing the plasma and the buffy coat (collectively PRP). - In
FIGS. 19I-1 and 19I-2 , the plasma and buffy coat (PRP) are transferred from the barrel into the syringe by either (a) retracting the plunger within thesyringe 180; or (b) by advancing therod 103 and thebarrel seal 104 within thebarrel 106. Thebarrel 106 is disconnected from the syringe and discarded, and a needle is attached to the syringe. -
FIG. 21 depicts an example of asyringe connector 200 which comprises an elongated tube having a lumen or through-hole 200L extending between proximal and distal ends thereof. Theconnector 200 is formed of a transparent material which permits visualization of fluids within the through-hole 200L. The proximal end is provided with a Luer-compatiblefemale taper 200P. Aflange 200F is provided proximate the distal end ofconnector 200. Between theflange 200F and the distal end of theconnector 200 is a region 200TS onto which thetube seal 108 is mounted.Flange 200F limits the amount thetube seal 108 can be advanced along the distal end of theconnector 200. An outer diameter of the connector in the region 200TS is sized to snugly (or sealingly) engage with the lumen or through-hole defined in thetube seal 108. The distal end ofconnector 200 may in some examples also be provided with a Luer-compatiblefemale taper 200P. -
FIG. 22 shows the tube seal mounted onto the region 200TS of theconnector 200 about to be inserted into aspecimen holder 602 containing a blood specimen which has been centrifuged thereby separating the blood specimen into distinct layers of RBC, buffy coat and plasma. -
FIG. 23 shows the connector ofFIG. 22 advanced into thecollection tube 602 and the plasma transferred from thecollection tube 602 into the through-hole 200L thereby de-airing the through-hole 200L. Fluid is transferred from the specimen holder to thesyringe 180 as thesyringe 180 andconnector 200 are advanced into the collection tube along withtube seal 108. Thetube seal 108 seals the collection tube such that the displaced fluid is transferred into thesyringe 180. -
FIG. 24 . shows the connector and collection tube ofFIG. 23 being coupled withsyringe 180. -
FIG. 25 shows the connector and collection tube ofFIG. 24 coupled withsyringe 180 after the plasma and buffy coat (platelet enriched plasma “PEP”) have been transferred from thecollection tube 602 throughconnector 200 into thesyringe 180. -
FIG. 26 shows thesyringe 180 ofFIG. 25 after it has been disconnected from theconnector 200. - While the exemplary embodiments have been described in some detail, by way of example and for clarity of understanding, those of skill in the art will recognize that a variety of modification, adaptations, and changes may be employed. The scope of the present invention may be limited solely by the appending claims.
Claims (9)
1. A method for transferring one or more portions of fluid from a specimen tube, comprising:
providing a specimen tube containing a fluid specimen;
centrifuging the specimen tube to separate the fluid specimen into at least a first layer having a density D1 and a second layer having a density D2 such that D2>D1;
providing an elongate connector, where the connector comprises an elongated tube having a lumen or through-hole extending between proximal and distal ends thereof, a Luer-compatible female taper provided on the proximal end of the connector, a flange provided proximate the distal end of the connector;
providing a tube seal mounted on the distal end of the connector, the tube seal comprising an elastomeric member having a longitudinal axis, a proximal end, a distal end, and a through-hole extending therebetween, the distal end having a frustoconical or chamfered face forming a funnel, the elastomeric member having an outer diameter sized to sealingly engage with an inner surface of the specimen tube;
advancing the distal end of the connector and the tube seal into the specimen tube, the funnel directing the first layer into the through-hole of the connector, wherein the distal end of the connector and the tube seal are advanced until the first layer at least partially fills the comprises, through-hole of the connector, thereby de-airing the connector;
providing a first syringe and connecting the first syringe to the female taper of the connector; and
advancing the distal end of the connector and the tube seal and the connected first syringe into the specimen tube until the first layer is transferred into the first syringe.
2. The method of claim 1 wherein the distal end of connector is provided with a Luer-compatible male or female taper.
3. The method of claim 1 , wherein:
the fluid specimen is blood;
the step of centrifuging the specimen tube separates the blood into a layer of plasma, a layer of buffy coat, and a layer of RBC, wherein the plasma has a density D1, the buffy coat has a density D2 and the RBC has a density D3 such that D3>D2>D1;
advancing the distal end of the connector and the tube seal and the connected first syringe into the specimen tube until the plasma or the plasma and buffy coat are transferred into the first syringe.
4. The method of claim 3 , wherein
before the step of providing the first syringe, providing a second syringe and connecting the second syringe to the female taper of the connector;
advancing the distal end of the connector and the tube seal and the connected second syringe into the specimen tube until between ½ and ¾ of the plasma is transferred into the second syringe; and
disconnecting the second syringe.
5. A connector, comprising:
an elongate tubular member having a proximal end, a distal end, and a lumen or through-hole extending therebetween, the tubular member formed of at least partially of a transparent or semi-transparent material;
a first Luer-compatible female taper provided on the proximal end of the connector; and
a flange provided proximate the distal end of the connector.
6. The connector of claim 5 , a second Luer-compatible male or female taper provided on the distal end of the connector.
7. The connector of claim 5 further comprising a tube seal mounted on the distal end of the connector, the tube seal including an elastomeric member having a longitudinal axis, a proximal end, a distal end, and a through-hole extending therebetween, the distal end having a frustoconical or chamfered face forming a funnel, the elastomeric member having an outer diameter sized to sealingly engage with an inner surface of a specimen tube.
8. A method for transferring one or more portions of fluid from a specimen tube into a syringe, comprising:
providing a specimen tube containing a tube seal and a fluid specimen, wherein tube seal includes an elastomeric member having a longitudinal axis, a proximal end, a distal end, and a through-hole extending therebetween, the distal end having a frustoconical or chamfered face forming a funnel, the elastomeric member having an outer diameter sized to sealingly engage with an inner surface of the specimen tube;
centrifuging the specimen tube to separate the fluid specimen into at least a first and a second layer of fluid, where the first layer of fluid has a density D1 and the second layer of fluid has a density D2 such that D2>D1;
providing an elongate connector, where the connector comprises an elongated tube having a lumen or through-hole extending between proximal and distal ends thereof, a Luer-compatible female taper provided on the proximal end of the connector, a flange provided proximate the distal end of the connector;
advancing the distal end of the connector into the specimen tube such that the distal end of the connector fluidically couples with a proximal end of the tube seal, the funnel directing the first layer of fluid into the through-hole of the connector, wherein the distal end of the connector and the tube seal are advanced until the first layer of fluid fills the through-hole of the connector, thereby de-airing the connector;
providing a first syringe and connecting the first syringe to the female taper of the connector; and
advancing the distal end of the connector and the tube seal and the connected first syringe into the specimen tube until the first layer of fluid is transferred into the first syringe.
9. A method for making platelet enriched plasma, comprising:
providing a specimen tube containing a centrifuged specimen of blood containing distinct layers of plasma, buffy coat and RBC;
providing an elongate connector, where the connector comprises an elongated tube having a lumen or through-hole extending between proximal and distal ends thereof, a Luer-compatible female taper provided on the proximal end of the connector, a flange provided proximate the distal end of the connector;
providing a tube seal mounted on the distal end of the connector, the tube seal comprising an elastomeric member having a longitudinal axis, a proximal end, a distal end, and a through-hole extending therebetween, the distal end having a frustoconical or chamfered face forming a funnel, the elastomeric member having an outer diameter sized to sealingly engage with an inner surface of the specimen tube;
advancing the distal end of the connector and the tube seal into the specimen tube, the funnel directing the plasma into the through-hole of the connector, wherein the distal end of the connector is advanced until the plasma at least partially fills the comprises, through-hole of the connector, thereby de-airing the connector;
providing a first syringe and connecting the first syringe to the female taper of the connector; and
advancing the distal end of the connector and the connected first syringe into the specimen tube until the plasma and buffy coat are transferred into the first syringe.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/525,719 US20220072534A1 (en) | 2020-07-15 | 2021-11-12 | Connector for Creating Platelet Rich Plasma |
PCT/US2022/023708 WO2023086122A1 (en) | 2020-07-15 | 2022-04-06 | Connector for creating platelet rich plasma |
US17/797,074 US12023425B2 (en) | 2022-04-06 | Connector for creating platelet rich plasma |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2020/042129 WO2022015303A1 (en) | 2020-07-15 | 2020-07-15 | Device, kit and methods for creating platelet rich plasma |
US17/258,864 US11759775B2 (en) | 2020-07-15 | 2020-07-15 | Device, kit and methods for creating platelet rich plasma |
US17/144,442 US11135580B1 (en) | 2020-07-15 | 2021-01-08 | Device, kit and methods for creating platelet rich plasma |
US17/462,627 US11325118B1 (en) | 2020-07-15 | 2021-08-31 | Device, kit and methods for creating platelet rich plasma |
US17/525,719 US20220072534A1 (en) | 2020-07-15 | 2021-11-12 | Connector for Creating Platelet Rich Plasma |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/462,627 Continuation US11325118B1 (en) | 2020-07-15 | 2021-08-31 | Device, kit and methods for creating platelet rich plasma |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/797,074 Continuation US12023425B2 (en) | 2022-04-06 | Connector for creating platelet rich plasma | |
US17/797,074 Continuation-In-Part US12023425B2 (en) | 2022-04-06 | Connector for creating platelet rich plasma |
Publications (1)
Publication Number | Publication Date |
---|---|
US20220072534A1 true US20220072534A1 (en) | 2022-03-10 |
Family
ID=77923670
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/144,442 Active US11135580B1 (en) | 2020-07-15 | 2021-01-08 | Device, kit and methods for creating platelet rich plasma |
US17/462,627 Active US11325118B1 (en) | 2020-07-15 | 2021-08-31 | Device, kit and methods for creating platelet rich plasma |
US17/525,719 Abandoned US20220072534A1 (en) | 2020-07-15 | 2021-11-12 | Connector for Creating Platelet Rich Plasma |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/144,442 Active US11135580B1 (en) | 2020-07-15 | 2021-01-08 | Device, kit and methods for creating platelet rich plasma |
US17/462,627 Active US11325118B1 (en) | 2020-07-15 | 2021-08-31 | Device, kit and methods for creating platelet rich plasma |
Country Status (2)
Country | Link |
---|---|
US (3) | US11135580B1 (en) |
WO (1) | WO2023086122A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11135580B1 (en) * | 2020-07-15 | 2021-10-05 | Prp Technologies Inc | Device, kit and methods for creating platelet rich plasma |
CA3236139A1 (en) * | 2021-11-11 | 2023-05-19 | Marcin Kowalewski | Specimen collection device |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3661265A (en) | 1970-07-27 | 1972-05-09 | Contemporary Research And Dev | Serum separator type container |
US6516953B1 (en) * | 1998-12-05 | 2003-02-11 | Becton, Dickinson And Company | Device for separating components of a fluid sample |
WO2005087292A1 (en) | 2004-03-11 | 2005-09-22 | Harvest Technologies Corporation | Method for obtaining an intermediate fraction in the centrifugal separation of blood |
CN101528243B (en) | 2006-10-27 | 2012-07-18 | 尼普洛株式会社 | Platelet-rich plasma separator and platelet-rich plasma separation method |
US8177072B2 (en) * | 2008-12-04 | 2012-05-15 | Thermogenesis Corp. | Apparatus and method for separating and isolating components of a biological fluid |
US9295788B2 (en) | 2011-03-04 | 2016-03-29 | Anestaweb, Inc. | Syringe with integrated cannula |
KR101472821B1 (en) | 2014-05-14 | 2014-12-16 | 김준우 | Component separator |
US10512659B2 (en) | 2015-07-02 | 2019-12-24 | Arthrex, Inc. | Methods and devices for preparation of enriched biological fluids |
DE102019121723A1 (en) * | 2019-08-13 | 2021-02-18 | Sarstedt Ag & Co. Kg | Separation bodies and methods for separating blood plasma and blood cells |
US11135580B1 (en) * | 2020-07-15 | 2021-10-05 | Prp Technologies Inc | Device, kit and methods for creating platelet rich plasma |
-
2021
- 2021-01-08 US US17/144,442 patent/US11135580B1/en active Active
- 2021-08-31 US US17/462,627 patent/US11325118B1/en active Active
- 2021-11-12 US US17/525,719 patent/US20220072534A1/en not_active Abandoned
-
2022
- 2022-04-06 WO PCT/US2022/023708 patent/WO2023086122A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
US11135580B1 (en) | 2021-10-05 |
WO2023086122A1 (en) | 2023-05-19 |
US11325118B1 (en) | 2022-05-10 |
US20240181140A1 (en) | 2024-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1202758B1 (en) | Platelet concentration syringe kit and method | |
US20220072534A1 (en) | Connector for Creating Platelet Rich Plasma | |
US6716187B1 (en) | Platelet concentration syringe kit | |
EP0778794B1 (en) | Centrifuge syringe apparatus and method | |
US7780860B2 (en) | Apparatus and method for separating and concentrating fluids containing multiple components | |
US7374678B2 (en) | Apparatus and method for separating and concentrating fluids containing multiple components | |
EP3031525B1 (en) | Apparatus and method for separating and concentrating fluids containing multiple components | |
US20190025162A1 (en) | Blood and Marrow Draw Processing Devices and Methods | |
US11345892B2 (en) | Centrifugal syringe and method for blood fractionation | |
US12023425B2 (en) | Connector for creating platelet rich plasma | |
US20220184600A1 (en) | Device, kit and methods for creating platelet rich plasma | |
CN210384934U (en) | Preparation facilities of rich platelet plasma | |
EP3302397B1 (en) | Syringe for cell isolation | |
CN112237755B (en) | Preparation method and preparation device of platelet-rich plasma and prepared platelet-rich plasma | |
CN216703068U (en) | Combined and detachable platelet-rich plasma preparation device | |
CN214077269U (en) | PRP extraction element | |
CA2967846A1 (en) | Centrifugal syringe and method for blood fractionation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: APPLICATION UNDERGOING PREEXAM PROCESSING |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- INCOMPLETE APPLICATION (PRE-EXAMINATION) |